Impact of co-morbid attention-deficit/hyperactivity disorder on self-perceived health-related quality-of-life of children with specific learning disability

被引:10
|
作者
Karande, Sunil [1 ]
Venkataraman, Rohini [1 ]
机构
[1] Lokmanya Tilak Municipal Med Coll & Gen Hosp, Learning Disabil Clin, Dept Pediat, Bombay, Maharashtra, India
关键词
Attention-deficit/hyperactivity disorder; dyslexia; quality of life; scholastic backwardness; students; ADHD;
D O I
10.4103/0019-5545.105507
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Background: About 12-24% of children with specific learning disability (SpLD) have co-occurring attention-deficit/hyperactivity disorder (ADHD). According to "parent-proxy reports", co-occurring "untreated" ADHD adversely impacts the health-related quality of life (HRQoL) of children with newly diagnosed SpLD, especially in their psychosocial functioning. Aims: To analyze the impact of "untreated" co-occurring ADHD on the "self-perceived" HRQoL of children with "newly diagnosed" SpLD. Setting and Design: Cross-sectional questionnaire-based study in a learning disability clinic situated in a medical college. Materials and Methods: From February 2008 to December 2008, 136 consecutive children newly diagnosed as having "SpLD with co-occurring ADHD (SpLD/ADHD)" or "SpLD only" were enrolled. The DISABKIDS chronic generic module (DCGM-37-S (V31)) instrument was used to measure their HRQoL. DCGM-37-S (V31) mean facet and total scores were computed for "SpLD/ADHD" and "SpLD only" children groups and compared using independent samples t-test. Results: HRQoL of "SpLD/ADHD" children was significantly better in limitation facet (mean difference: 8.20; 95% confidence interval (CI): 1.75-15.29; P=0.024). Although not statistically significant, the HRQoL of "SpLD/ADHD" children was better in independence, emotion, social inclusion and social exclusion facets; and in total score. Conclusions: "SpLD/ADHD" children perceive their physical functioning to be significantly better. Also their perceptions of their psychosocial functioning are better. Contrary to parent-proxy reports, co-occurring "untreated" ADHD does not adversely impact the self-perceived HRQoL of children with "newly diagnosed" SpLD.
引用
收藏
页码:52 / 58
页数:7
相关论文
共 50 条
  • [41] Review of the evidence for the management of co-morbid Tic disorders in children and adolescents with attention deficit hyperactivity disorder
    Michael O Ogundele
    Hani F Ayyash
    World Journal of Clinical Pediatrics, 2018, (01) : 36 - 42
  • [42] Attention deficit hyperactivity disorder among Nigerian primary school children - Prevalence and co-morbid conditions
    Adewuya, Abiodun O.
    Famuyiwa, Oluwole O.
    EUROPEAN CHILD & ADOLESCENT PSYCHIATRY, 2007, 16 (01) : 10 - 15
  • [43] Attention deficit hyperactivity disorder among Nigerian primary school children Prevalence and co-morbid conditions
    Abiodun O. Adewuya
    Oluwole O. Famuyiwa
    European Child & Adolescent Psychiatry, 2007, 16 : 10 - 15
  • [44] The Impact of Medications on Quality of Life in Attention-Deficit Hyperactivity Disorder A Systematic Review
    Coghill, David
    CNS DRUGS, 2010, 24 (10) : 843 - 866
  • [45] Health-related quality of life in cases of attention deficit hyperactivity disorder with and without pharmacological treatment
    Antonio Lopez-Villalobos, Jose
    Maria Sacristan-Martin, Ana
    Garrido-Redondo, Mercedes
    Teresa Martinez-Rivera, Maria
    Victoria Lopez-Sanchez, Maria
    Rodriguez-Molinero, Luis
    Belen Camina-Gutierrez, Ana
    Andres-de Llano, Jesus
    ANALES DE PEDIATRIA, 2019, 90 (05): : 272 - 279
  • [46] Actual Motor Performance and Self-Perceived Motor Competence in Children With Attention-Deficit Hyperactivity Disorder Compared With Healthy Siblings and Peers
    Fliers, Ellen A.
    de Hoog, Marieke L. A.
    Franke, Barbara
    Faraone, Stephen V.
    Rommelse, Nanda N. J.
    Buitelaar, Jan K.
    Nijhuis-van der Sanden, Maria W. G.
    JOURNAL OF DEVELOPMENTAL AND BEHAVIORAL PEDIATRICS, 2010, 31 (01): : 35 - 40
  • [47] Aripiprazole in Children with Tourette's Disorder and Co-morbid Attention-Deficit/Hyperactivity Disorder: A 12-Week, Open-Label, Preliminary Study
    Masi, Gabriele
    Gagliano, Antonella
    Siracusano, Rosamaria
    Berloffa, Stefano
    Calarese, Tiziana
    Ilardo, Giovanna
    Pfanner, Chiara
    Magazu, Angela
    Cedro, Clemente
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2012, 22 (02) : 120 - 125
  • [48] Quality-of-life assessment in atomoxetine-treated adult patients with attention-deficit/hyperactivity disorder
    Adler, L
    Kelsey, DK
    Dietrich, A
    Reimherr, F
    Sangal, RB
    Saylor, K
    Secnik, K
    Sutton, V
    Moore, R
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2004, 14 : S367 - S367
  • [49] Treatment Response in Depressed Adolescents With and Without Co-Morbid Attention-Deficit/Hyperactivity Disorder in the Treatment for Adolescents with Depression Study
    Kratochvil, Christopher J.
    May, Diane E.
    Silva, Susan G.
    Madaan, Vishal
    Puumala, Susan E.
    Curry, John F.
    Walkup, John
    Kepley, Hayden
    Vitiello, Benedetto
    March, John S.
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2009, 19 (05) : 519 - 527
  • [50] Substance use disorders in association with attention-deficit/hyperactivity disorder, co-morbid mental disorders, and medication in a nationwide sample
    Steinhausen, Hans-Christoph
    Bisgaard, Charlotte
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2014, 24 (02) : 232 - 241